Detlef Rohm

Title: The Innovations of Detlef Rohm

Introduction

Detlef Rohm is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of two patents to his name, Rohm's work focuses on advancements in antibody technology and immunoglobulin preparations.

Latest Patents

Rohm's latest patents include "Human monoclonal anti-rhesus (D) antibodies and cell lines producing same." This invention relates to two human monoclonal antibodies of subclasses IgG1 and IgG3, specifically targeting the Rhesus D antigen. The pharmaceutical composition developed is intended for the prophylaxis of hemolytic disease in newborns. Additionally, he has patented a method for "Manufacturing intravenous tolerable immunoglobulin-G preparation." This method ensures the preparation is free of aggregates, vasoactive substances, and proteolytic enzymes, making it suitable for all types of patients, especially those who are immunosuppressed.

Career Highlights

Throughout his career, Detlef Rohm has worked with several prominent companies, including Biotest Pharma GmbH and the Association Pour L'essor De La Transfusion Sanguine Dans La Region Du. His expertise in immunology and patent development has positioned him as a key figure in the industry.

Collaborations

Rohm has collaborated with notable colleagues such as Michael Kloft and Norbert Kothe. These partnerships have further enhanced his research and development efforts in the field of immunology.

Conclusion

Detlef Rohm's contributions to the field of immunology through his patents and collaborations highlight his innovative spirit and dedication to advancing medical science. His work continues to impact the development of crucial medical treatments.